$0.2990
At close: Apr 15 EDT
Comments
Loading...
Cell Source Analyst Ratings and Price Targets | OTC:CLCS | Benzinga
Cell Source Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cell Source Corp from these most-recent analyst ratings.
Analyst Ratings for Cell Source
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Cell Source (CLCS) stock?
There is no price target for Cell Source
What is the most recent analyst rating for Cell Source (CLCS)?
There is no analyst for Cell Source
When was the last upgrade for Cell Source (CLCS)?
There is no last upgrade for Cell Source
When was the last downgrade for Cell Source (CLCS)?
There is no last downgrade for Cell Source.
When is the next analyst rating going to be posted or updated for Cell Source (CLCS)?
There is no next analyst rating for Cell Source.
Is the Analyst Rating Cell Source (CLCS) correct?
There is no next analyst rating for Cell Source.
Browse analyst ratings and price targets on all stocks.